Legal & General Group PLC Angion Biomedica Corp. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 22, 2022
SELL
$1.1 - $2.23 $2,491 - $5,050
-2,265 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.31 - $13.25 $15,780 - $22,458
1,695 Added 297.37%
2,265 $22,000
Q1 2021

May 17, 2021
BUY
$15.01 - $25.74 $8,555 - $14,671
570 New
570 $10,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email